Mibolerone

Mibolerone
Systematic (IUPAC) name
(7α,17β)-17-hydroxy-7,17-dimethylestr-4-en-3-one
Clinical data
AHFS/Drugs.com International Drug Names
Pregnancy cat.  ?
Legal status Schedule 3 (US)
Routes Oral
Pharmacokinetic data
Metabolism Hepatic
Half-life 2-4 hours
Identifiers
CAS number 3704-09-4 N
ATC code None
PubChem CID 251636
ChemSpider 220460 Y
UNII 9OGY4BOR8D Y
KEGG D05025 Y
ChEMBL CHEMBL425863 Y
Synonyms (7R,8R,9S,10R,13S,14S,17S)-17-Hydroxy-7,13,17-trimethyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
Chemical data
Formula C20H30O2 
Mol. mass 302.4558 g/mol
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

Mibolerone is a potent anabolic steroid which is both higher affinity[1] and more selective[2] for the androgen receptor than metribolone.

Under the brand name "Cheque Drops", Mibolerone was marketed as a veterinary drug by the Upjohn company. It was indicated as an oral treatment for estrous (heat) prevention in adult female dogs.

References

  1. ^ Murthy LR, Johnson MP, Rowley DR, Young CY, Scardino PT, Tindall DJ (1986). "Characterization of steroid receptors in human prostate using mibolerone". Prostate 8 (3): 241–53. doi:10.1002/pros.2990080305. PMID 2422638. 
  2. ^ Schilling K, Liao S (1984). "The use of radioactive 7 alpha, 17 alpha-dimethyl-19-nortestosterone (mibolerone) in the assay of androgen receptors". Prostate 5 (6): 581–8. doi:10.1002/pros.2990050603. PMID 6333679.